Results 181 to 190 of about 60,909 (346)

Vegan diet and nutritional status in infants, children and adolescents: A position paper based on a systematic search by the ESPGHAN Nutrition Committee

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Vegan and other plant‐based diets are becoming increasingly popular in the paediatric age group. There is limited evidence in the current medical literature to determine whether a vegan diet is adequate for children, since the currently available society position papers are based on narrative reviews and expert opinion.
Elvira Verduci   +11 more
wiley   +1 more source

Reference interval for transthyretin in children ages six to 60 months [PDF]

open access: bronze, 1990
Abdellatif Chakar   +4 more
openalex   +1 more source

Microvascular obstruction in cardiac amyloidosis

open access: yes
European Journal of Heart Failure, EarlyView.
Lucrezia Netti   +19 more
wiley   +1 more source

Optimized reconstruction of undersampled Dixon sequences using new memory‐efficient unrolled deep neural networks: HalfVarNet and HalfDIRCN

open access: yesMagnetic Resonance in Medicine, EarlyView.
Abstract Purpose Fat fraction (FF) quantification in individual muscles using quantitative MRI is of major importance for monitoring disease progression and assessing disease severity in neuromuscular diseases. Undersampling of MRI acquisitions is commonly used to reduce scanning time. The present paper introduces novel unrolled neural networks for the
Sandra Martin   +6 more
wiley   +1 more source

The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France

open access: yesOrphanet Journal of Rare Diseases
Background The containment strategies during the COVID-19 pandemic between December 2019 and 2022 significantly disrupted the healthcare system. Cardiac amyloidosis has a poor prognosis and requires frequent follow-up in reference centres.
D. Guijarro   +20 more
doaj   +1 more source

A functional role for spontaneously occurring natural anti‐transthyretin antibodies from patients with transthyretin cardiac amyloidosis

open access: yes
European Journal of Heart Failure, EarlyView.
Ortal Tuvali   +5 more
wiley   +1 more source

Sural/Radial Amplitude Ratio: A Useful Tool to Diagnose Non‐Length‐Dependent Neuropathy

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Patients with non‐length‐dependent neuropathy (NLDN) exhibit reduced sensory nerve action potential (SNAP) amplitudes in both lower and upper limbs. This study aimed to determine a threshold for the sural/radial amplitude ratio (SRAR) suggestive of NLDN.
Antoine Pegat   +6 more
wiley   +1 more source

Experience of Hereditary Amyloidosis with Rare Variant in Ecuador: Case Reports

open access: yesMedical Sciences
More than approximately 120 transthyretin mutations are known. Their clinical presentation is heterogeneous, as the course of disease onset depends on genetic variation and level of penetrance.
Diana Elizabeth Luzuriaga Carpio   +2 more
doaj   +1 more source

State‐of‐the‐Art on Model‐Informed Drug Development Approaches for Pediatric Rare Diseases

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pediatric rare diseases present unique challenges for drug development due to small patient populations, ethical constraints on clinical trial design, and limited prospectively defined natural history data. Model‐Informed Drug Development (MIDD) has emerged as a powerful paradigm to address these challenges by leveraging quantitative methods ...
Rajesh Krishna   +4 more
wiley   +1 more source

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

open access: yesSmall, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy